Andrew K. Balo

Companies

• Glucotrack, Inc.Board member Mar 28, 2025 to now¹
• DexcomVP of Clinical & Regulatory May 4, 2006 to Mar 14, 2023²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• Dexcom DXCM81,120 shares³$7.0M at $86.09Mar 14, 2023
• GGlucotrack, Inc. GCTK4,692 shares⁴$3.3K at $0.71Oct 3, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

• Oct 3, 2025Granted 1,285 shares of Glucotrack, Inc.⁴
• Jul 11, 2025Granted 3,332 shares of Glucotrack, Inc.⁴
• Mar 26, 2025Granted 4,490 shares of Glucotrack, Inc.⁵
• Mar 25, 2025Granted 75 shares of Glucotrack, Inc.⁴
• Mar 10, 2023Returned to company 5,990 shares at $111.40 of Dexcom³
• Mar 10, 2023Returned to company 2,405 shares at $111.40 of Dexcom³
• Mar 10, 2023Returned to company 3,275 shares at $111.40 of Dexcom³
• Mar 9, 2022Returned to company 949 shares at $406.06 of Dexcom⁶
• Mar 9, 2022Returned to company 1,549 shares at $406.06 of Dexcom⁶
• Mar 9, 2022Returned to company 932 shares at $406.06 of Dexcom⁶
• Mar 8, 2022Granted 4,984 shares of Dexcom⁶